Amgen, Juno And The Fate Of Functional Genus Claims
The U.S. Court of Appeals for the Federal Circuit issued two significant decisions last year that affect the protection of biotechnology through the use of functional genus claims — Amgen Inc....To view the full article, register now.
Already a subscriber? Click here to view full article